Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy

PLoS Pathogens(2021)10.1371/journal.ppat.1009141Source: DataRank Database

Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy is a research paper published in PLoS Pathogens (2021). On theSindex it has a DataRank of 0. It has been cited 67 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access67 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 6.98)OA: goldTopics (52)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Michael J. Bale ORCID,Daria Wells ORCID,Shuang Guo ORCID,Brian T. Luke ORCID,Jennifer M. Zerbato ORCID

Live enrichment

PubMed:33826675 OpenAlex:https://openalex.org/W3150230452

Leidos/National Cancer Institute

Grant: l3XS110

National Cancer Institute

Grant: R35 CA200421

Leidos/National Cancer Institute

Grant: 12XS547

National Cancer Institute

Grant: HHSN261200800001E

National Institutes of Health

Grant: 5R35CA200421-03

Retrovirus Evolution and Cancer

CCR NIH HHS

Grant: HHSN261200800001C

FWCI

6.98

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009141&type=printable

publisherhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009141&type=printable

publisherhttps://dx.plos.org/10.1371/journal.ppat.1009141

journalhttps://doi.org/10.1371/journal.ppat.1009141

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33826675

Fields of Study

HIV Research and TreatmentHIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions0301 basic medicine0303 health sciences03 medical and health sciencesAnti-Retroviral AgentsCD4-Positive T-LymphocytesDNA, ViralHIV InfectionsHumansLeukocytes, MononuclearOncogenesProvirusesVirus Replication

MeSH Terms

DNA, ViralHumansLeukocytes, MononuclearOncogenesProvirusesVirus ReplicationCD4-Positive T-LymphocytesHIV InfectionsAnti-Retroviral Agents

Keywords

ProvirusBiologyPeripheral blood mononuclear cellGenomeIn vivoVirologyGeneAntiretroviral therapyDistribution (mathematics)VirusIn vitroGeneticsViral loadCD4-Positive T-LymphocytesQH301-705.5610HIV InfectionsOncogenesRC581-607Virus ReplicationAnti-Retroviral AgentsProvirusesDNA, ViralLeukocytes, MononuclearHumansImmunologic diseases. AllergyBiology (General)Research Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being